Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 278

Corporate venturing deal net: 6-10 May 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

May 10, 2019

Twentyeight-Seven recalculates series A round

Johnson & Johnson, Novartis and Astellas all took part in the first close of a round for oncology therapy developer 28-7 Therapeutics that now stands at $82.8m.

May 10, 2019

Milestone Pharmaceuticals progresses to flotation

Milestone, a cardiovascular nasal spray developer that raised more than $167m in VC funding from investors including Novo, secured $82.5m in when it went public.

May 10, 2019

MGI Tech takes $200m

BGI's gene sequencer spinoff, MGI Tech, has secured $200m in funding from Goldstone Investment, Green Pine Capital and Orient Securities despite a reported $1bn target.

May 10, 2019

Cortexyme courses to $75m IPO

Pfizer, Takeda and Alphabet-backed degenerative disease drug developer Cortexyme priced its initial public offering in the middle of its range to raise $75m.

May 10, 2019

DispatchHealth gets $33m funding delivery

Corporate joint venture Echo Health Ventures led a $33m funding round that will help fund the home care access platform's expansion in the US.

May 10, 2019

Neural Analytics nets $22m

TigerMed-backed brain monitor developer Neural Analytics boosted its total funding to $66m in a series C round led by existing investor Alpha Edison.

May 9, 2019

Pfizer feels its way to $340m Therachon acquisition

Therachon, which had raised $100m from investors including Pfizer Ventures and Novo, has agreed to be acquired by Pfizer in a deal that could potentially reach $810m.

May 9, 2019

Verve Therapeutics pumps in series A funding

GV led a $58.5m round for the heart disease drug developer, which came in the wake of a partnership with another Alphabet subsidiary, Verily.

May 9, 2019

Medlife makes a move for Myra

Bennett, Coleman & Co has exited online pharmacy Myra and will receive shares in its new owner, Medlife, as part of the acquisition deal.

May 8, 2019

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here